The Academy of Medical Sciences and Academy of Sciences South Africa (ASSAF) convened a policy workshop on the prevention and management of multimorbidity in sub-Saharan Africa in Johannesburg on the 5-6 September 2019.
The Academy of Medical Sciences and National Academy of Science of Sri Lanka convened a policy workshop on non-communicable diseases in South Asia and beyond in Sri Lanka on the 23-24 January 2020.
The Academy of Medical Sciences and InterAcademy Partnership convened a policy workshop on research and Universal Health Coverage in low and middle income countries in London on the 29-30 May 2019.
As part of our wider programme on antimicrobial resistance (AMR), the Academy is hosted two scientific meetings in 2019 and 2024 to strengthen the research links between the UK and India to jointly address the challenge of AMR.
On Thursday 29 November 2018, the Academy of Medical Sciences and the French Académie Nationale de Médecine held a one-day symposium on mental health and addictions. at the Académie Nationale de Médecine in Paris.
Dr Irene Akua Agyepong delivered the 2018 Academy of Medical Sciences and The Lancet International Health Lecture under the title 'Universal Health Coverage: Global policy agenda breakthrough or great white elephant'?
The preclinical-clinical boundary is a key checkpoint in the translational pathway for research. It refers to the point at which preclinical evidence is considered sufficient to merit the move to first-in-human clinical studies, and represents a significant escalation in both resourcing and time, with a high risk of failure. Therefore there is a drive to ensure that the evidence base for progression into clinical studies is as robust and predictive as possible to maximise the chances of success and minimise risk of failure.
One of the key ways to improve cancer outcomes is to detect and diagnose at an earlier stage when cancers are far more treatable. However, a limitation to the earlier diagnosis of some cancers is the lack of technologies that can detect very early indicators of disease. This means research into novel tests and innovations, and the rapid implementation of effective interventions into the healthcare system, are crucial.
The Academy of Medical Sciences, in collaboration with the Philippines National Academy of Science and Technology (NAST), convened a policy workshop on rapid diagnostic tests in South East Asia in Manila, Philippines on the 23-24 October 2018.